Results 211 to 220 of about 7,279 (231)
A rare case of Rosai-Dorfman disease mimicking a malignant lymphoproliferative process and IgG4-related disease. [PDF]
Czerwiński J +6 more
europepmc +1 more source
Diagnostic Challenges in Intracranial Rosai-Dorfman Disease: Differentiating It From Meningiomas Using Imaging. [PDF]
Mourad JF, Bryniarski M.
europepmc +1 more source
Rosai-Dorfman Disease Presenting as a Bone-Destructive Mass in the Maxillary Sinus With Orbital Extension: A Diagnostic and Therapeutic Challenge. [PDF]
Junicho M +3 more
europepmc +1 more source
Rosai-Dorfman Disease Mimicking Metastatic Disease. [PDF]
Velasco S +2 more
europepmc +1 more source
Radiation Therapy for Primary Cutaneous Rosai-Dorfman Disease of the Face: A Case Report Resistant to Multiple Lines of Treatment and a Literature Review. [PDF]
Lopez Navarro OG +11 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Intracranial Rosai–Dorfman disease
Journal of Clinical Neuroscience, 2016Rosai-Dorfman disease (RDD) is a rare histioproliferative disorder that only occasionally involves the central nervous system. We present the diagnosis and treatment of five patients with intracranial RDD. The patients were preoperatively misdiagnosed as meningioma or eosinophilic granuloma.
Bo Yuan, Huang +5 more
openaire +2 more sources
American Journal of Gastroenterology, 2017
Rosai–Dorfman disease (RDD) is a benign non-Langerhans cell histiocytic disorder that usually presents with massive lymphadenopathy and sinus histiocytosis, although at least 40% of patients can have extranodal involvement. Recent studies found NRAS, KRAS, and ARAF mutations in a subset of patients with RDD, but no BRAF-V600E mutations have been ...
G. Petur Nielsen +5 more
+4 more sources
Rosai–Dorfman disease (RDD) is a benign non-Langerhans cell histiocytic disorder that usually presents with massive lymphadenopathy and sinus histiocytosis, although at least 40% of patients can have extranodal involvement. Recent studies found NRAS, KRAS, and ARAF mutations in a subset of patients with RDD, but no BRAF-V600E mutations have been ...
G. Petur Nielsen +5 more
+4 more sources
Cutis, 2015
Rosai-Dorfman disease is a rare systemic disease characterized by a histiocyte proliferation which presents with lymphadenopathy. Some patients present with extranodal disease.
Alyssa, Miceli +2 more
+5 more sources
Rosai-Dorfman disease is a rare systemic disease characterized by a histiocyte proliferation which presents with lymphadenopathy. Some patients present with extranodal disease.
Alyssa, Miceli +2 more
+5 more sources

